Key Takeaways
- • Assort Health closed a $120 million Series C funding round led by Menlo Ventures, bringing total capitalization to $222 million and signaling sustained investor confidence in AI-driven healthcare automation.
- • The company hired three senior executives—Jon Corn (Chief Revenue Officer), Kristina Kemp (Vice President of Customer Success), and Emil Yeargin (Senior Vice President of People)—positioning for scaled revenue growth and operational maturity.
- • Assort's platform demonstrates quantified customer impact: a 5% lift in appointment volume, 115% increase in labor capacity, and 4.3 out of 5 patient satisfaction score across its user base of 200 million specialty patient interactions.
- • The funding syndicate included Lightspeed Venture Partners, Felicis, First Round Capital, and Tau Venture, indicating broad institutional support for the healthcare AI agents vertical.
- • Native integrations with major EHR systems (Epic and Athena) and deployment without clinical workflow disruption position Assort to capture multi-site practices, multi-specialty groups, and health systems seeking complexity management beyond general-purpose AI solutions.
Summary
Assort Health, a healthcare-focused artificial intelligence platform specializing in patient journey automation, has secured $120 million in Series C funding led by Menlo Ventures. The capital raise brings the company's total funding to $222 million and follows the company's annual Ascend customer summit, which drew more than 200 healthcare leaders. Additional investors participating in the round include Lightspeed Venture Partners, Felicis, First Round Capital, and Tau Venture.
The platform addresses a specific market gap: automating the complex, multi-step patient interaction workflows that general-purpose AI systems cannot reliably handle. Assort's foundation rests on 200 million specialty patient interactions and a proprietary model that updates in real time to accommodate healthcare-specific complexity. The system manages the full patient journey—from scheduling and intake through referrals, forms, document processing, medication refills, and payments—and integrates natively with leading EHR and practice management systems including Epic and Athena.
The company is backing the capital raise with organizational strengthening, announcing three senior executive hires contemporaneously. Jon Corn joins as Chief Revenue Officer, Kristina Kemp as Vice President of Customer Success, and Emil Yeargin as Senior Vice President of People. These appointments signal intention to scale revenue operations and build the human infrastructure required to support enterprise deployment across large health systems and multi-specialty provider groups.
Customer metrics indicate material operational utility. According to the company, customers experience a 5% lift in appointment volume, a 115% increase in labor capacity, and achieve a 4.3 out of 5 patient satisfaction score. The deployment model—which integrates with existing clinical workflows without disrupting operations—addresses a primary adoption barrier for healthcare technology in large organizations. The funding and leadership expansion position Assort to pursue multi-site practices, multi-specialty groups, and health systems where operational complexity has outpaced legacy tooling capabilities.
The platform addresses a specific market gap: automating the complex, multi-step patient interaction workflows that general-purpose AI systems cannot reliably handle. Assort's foundation rests on 200 million specialty patient interactions and a proprietary model that updates in real time to accommodate healthcare-specific complexity. The system manages the full patient journey—from scheduling and intake through referrals, forms, document processing, medication refills, and payments—and integrates natively with leading EHR and practice management systems including Epic and Athena.
The company is backing the capital raise with organizational strengthening, announcing three senior executive hires contemporaneously. Jon Corn joins as Chief Revenue Officer, Kristina Kemp as Vice President of Customer Success, and Emil Yeargin as Senior Vice President of People. These appointments signal intention to scale revenue operations and build the human infrastructure required to support enterprise deployment across large health systems and multi-specialty provider groups.
Customer metrics indicate material operational utility. According to the company, customers experience a 5% lift in appointment volume, a 115% increase in labor capacity, and achieve a 4.3 out of 5 patient satisfaction score. The deployment model—which integrates with existing clinical workflows without disrupting operations—addresses a primary adoption barrier for healthcare technology in large organizations. The funding and leadership expansion position Assort to pursue multi-site practices, multi-specialty groups, and health systems where operational complexity has outpaced legacy tooling capabilities.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.